Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

The effects of zoledronic acid on the progression of experimental periodontitis in rats: histological and microtomographic analyses

Journal of Periodontal & Implant Science 2021³â 51±Ç 4È£ p.264 ~ 275
de Marcelos Priscylla Goncalves Correia Leite, da Cruz Perez Perez Danyel Elias, Soares Diego Moura, de Araujo Samuel Silva, Evencio Liriane Baratella, dos Anjos Pontual Maria Luiza, de Moraes Ramos-Perez Flavia Maria,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( de Marcelos Priscylla Goncalves Correia Leite ) - Universidade Federal de Alagoas School of Dentistry
 ( da Cruz Perez Perez Danyel Elias ) - Universidade Federal de Pernambuco School of Dentistry Department of Clinical and Preventive Dentistry
 ( Soares Diego Moura ) - Universidade Federal de Pernambuco School of Dentistry Department of Clinical and Preventive Dentistry
 ( de Araujo Samuel Silva ) - Universidade Federal de Pernambuco School of Dentistry Department of Clinical and Preventive Dentistry
 ( Evencio Liriane Baratella ) - Universidade Federal de Pernambuco Department of Histology
 ( dos Anjos Pontual Maria Luiza ) - Universidade Federal de Pernambuco School of Dentistry Department of Clinical and Preventive Dentistry
 ( de Moraes Ramos-Perez Flavia Maria ) - Universidade Federal de Pernambuco School of Dentistry Department of Clinical and Preventive Dentistry

Abstract


Purpose: Periodontitis is considered a local risk factor for medication-related osteonecrosis of the jaws (MRONJ). However, little is known about the progression of periodontitis in the presence of zoledronic acid (ZOL). The aim of this study was to evaluate the effects of the systemic use of ZOL on the progression of experimental periodontitis (EP) in rats, as ZOL could modulate the progression of periodontitis and concomitantly cause MRONJ in individuals with periodontitis.

Methods: Forty-eight male Wistar rats were randomly distributed in 6 groups (n=8 each). To induce EP, ligatures were placed around the right first mandibular molars. Three groups were treated with ZOL (0.15 mg/kg/week, intraperitoneal), and 3 with 0.9% saline solution (controls). In the ZOL/Lig30 and ZOL/Lig 15 groups, after 4 weeks of treatment with ZOL, EP was induced and euthanasia was performed after 30 and 15 days of EP induction, respectively. In both groups, the animals continued to receive ZOL after EP until the end of the experiment. In the Lig/ZOL group, EP was induced first, and 15 days later, ZOL was administered for 8 weeks, with euthanasia 1 week after the last dose. After euthanasia, the mandibles were evaluated using micro-computed microtomography (micro-CT) and histomorphometry. Bone loss was measured, and the presence of osteonecrosis was evaluated histologically. The data were evaluated using the Student t-test and the Mann-Whitney test, with a significance level of 5%.

Results: In the Lig/ZOL group, micro-CT revealed less alveolar bone resorption in the distal root (P<0.01) than in the control group (Lig/Con). Histomorphometric analysis confirmed less alveolar bone resorption in the Lig/ZOL group (P=0.001). Histologically, osteonecrosis was more common in the ZOL groups.

Conclusion: ZOL decreased alveolar bone resorption in rats with EP. However, it presented a higher risk for MRONJ.

Å°¿öµå

Histology; Osteonecrosis; Periodontitis; Rats; X-ray microtomography; Zoledronic acid

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

SCI(E)
KCI
KoreaMed